Active ingredientFlunarizine DihydrochlorideCat. No. P-F081-001CAS 30484-77-6Family · Pharmaceutical analytical standards
Flunarizine
A calcium antagonist discovered in 1968 in Belgium, related to cinnarizine, used mainly to prevent migraine and to treat vertigo. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?In the brain it reaches concentrations about ten times higher than in the blood and, with daily use, it has a very long half-life: about 18 to 19 days.
Go to the active ingredient →Active ingredientFlunarizine DihydrochlorideCat. No. P-F081-001CAS 30484-77-6
Pharmacopoeial impurityFlunarizine EP Impurity ACat. No. P-F081-002CAS 27469-60-9
Pharmacopoeial impurityFlunarizine EP Impurity B DihydrochlorideCat. No. P-F081-003CAS 27064-96-6
Pharmacopoeial impurityFlunarizine EP Impurity C DihydrochlorideCat. No. P-F081-004CAS 2734416-95-4
Pharmacopoeial impurityFlunarizine EP Impurity D DihydrochlorideCat. No. P-F081-006CAS 693765-11-6
Impurity1,4-dicinnamylpiperazineCat. No. P-F081-008CAS 88172-16-1
Impurity4,4'-Difluorobenzhydryl alcoholCat. No. P-F081-009CAS 365-24-2
Impurity4,4'-DifluorobenzophenoneCat. No. P-F081-010CAS 345-92-6
ImpurityFlunarizine N-OxideCat. No. P-F081-011CAS 123375-94-0
ImpurityChlorobis-(4-fluorophenyl)methaneCat. No. P-F081-012CAS 27064-94-4
ImpurityFlunarizine Impurity 1Cat. No. P-F081-013CAS 87166-81-2
ImpurityFlunarizine Impurity 2Cat. No. P-F081-014
ImpurityFlunarizine N,N-DioxideCat. No. P-F081-015No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceFlunarizine dihydrochloride CRSEDQM code F0189900Family FlunarizineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.